Class IV laser therapy — also termed high-intensity laser therapy (HILT) — uses therapeutic lasers with power output >500 mW (typically 1–25 W), distinguishing it from low-level laser therapy (LLLT, <500 mW). The higher power enables deeper tissue penetration while maintaining photobiomodulation effects. The strongest evidence supports its use in musculoskeletal pain (particularly knee OA, frozen shoulder, low back pain, and neck pain), tendinopathy, and oral mucositis, though overall evidence quality remains low to moderate across domains.
Musculoskeletal Pain — The Broadest Evidence Base
A comprehensive meta-analysis of 48 RCTs found HILT significantly reduced pain (MD = −1.3 cm on VAS; 95% CI −1.6 to −1.0) and improved functionality (SMD = −1.0; 95% CI −1.4 to −0.7), with greater effects compared to control/no treatment than to other active conservative treatments. An umbrella review of 20 systematic reviews (14 with meta-analyses) identified the strongest analgesic effects by condition:
- Frozen shoulder: MD = −2.23 cm (95% CI −3.3 to −1.2)
- Knee osteoarthritis: MD = −1.9 cm (95% CI −2.0 to −1.8)
- Low back pain: MD = −1.9 cm (95% CI −2.9 to −1.0)
- Myofascial pain: MD = −1.9 cm (95% CI −2.6 to −1.2)
- Neck pain: largest effect size (SMD = 2.1; 95% CI 1.2 to 3.0)
However, the umbrella review noted that the methodological quality of the underlying systematic reviews was generally low to critically low on AMSTAR-2, with key weaknesses in publication bias assessment, funding disclosure, and heterogeneity discussion.
Knee Osteoarthritis — Most Studied Condition
A network meta-analysis of 10 RCTs (n = 580) ranked HILT as having the highest probability of being the most effective physical therapy modality for KOA pain (SUCRA = 100%), with a significant VAS reduction of 1.66 cm versus control (95% CI 1.48–1.84). A double-blind placebo-controlled RCT (n = 40) confirmed HILT + exercise produced significantly greater improvements in VAS, WOMAC, flexion ROM, and notably increased femoral cartilage thickness on ultrasound at 6 weeks compared to placebo + exercise.
When compared head-to-head with LLLT in a double-blind RCT (n = 90), HILT + exercise produced more pronounced improvements in pain, functionality, and flexion ROM at 6 weeks, though both modalities improved cartilage thickness equally. The AAOS Clinical Practice Guideline for knee OA includes laser treatment with a "Limited" strength recommendation, acknowledging favorable pain data but downgrading for feasibility and practice usage concerns.
Low Back Pain
A meta-analysis of RCTs found HILT significantly reduced pain intensity (MD = −1.65; 95% CI −2.22 to −1.09; p < 0.00001) and improved disability on both the Oswestry (MD = −0.67) and Roland indices (MD = −1.36) compared to controls. A sham-controlled RCT using pulsed Nd:YAG laser showed significant improvements in pain, disability, and lumbar ROM after 6 weeks, while the sham group showed no change. When compared directly to LLLT in an RCT (n = 60), both modalities produced equivalent improvements in pain, disability, lumbar mobility, and quality of life — with no significant difference between HILT and LLLT.
Frozen Shoulder
A meta-analysis of 5 RCTs found HILT significantly reduced pain (MD = −2.23 cm on VAS) and disability (SPADI MD = −10.1%), both reaching clinical significance. However, HILT did not improve shoulder ROM (flexion, abduction, or external rotation) beyond conventional physical therapy. A sham-controlled RCT (n = 36) confirmed HILT was superior for pain and quality of life but not for disability or ROM.
Tendinopathy
A meta-analysis of 15 RCTs (n = 629) found HILT significantly improved pain (MD = −1.15; 95% CI −1.73 to −0.58) and disability (SMD = −1.00) in tendinopathy, with pain reduction exceeding the MCID. Key subgroup findings:
- Shoulder tendinopathy showed greater disability improvement (MD = −2.54) than elbow conditions (MD = −0.91)
- Stress pain showed the most substantial relief (MD = −2.30)
- Treatment effects were cumulative, peaking after 16 weeks
For lateral epicondylitis specifically, a meta-analysis of 12 RCTs found both HILT and LLLT effectively reduced pain, with HILT showing superior grip strength improvement while LLLT demonstrated more consistent pain relief significance. Laser combined with bandage produced synergistic effects.
For rotator cuff tendinopathy, a systematic review found HILT showed greater effect sizes than LLLT for both pain (Hedges' g = −0.701) and disability (Hedges' g = −0.691), with standalone LLLT showing limited effectiveness.
HILT vs. LLLT — Head-to-Head Comparisons
A network meta-analysis of 22 RCTs (n = 1,353) found HILT produced statistically greater pain reduction than LLLT in some comparisons, but the magnitude was generally modest and frequently below MCID thresholds. Evidence for disability and ROM differences was insufficient. The certainty of evidence was predominantly very low per GRADE. A separate systematic review of 12 RCTs (n = 704) across multiple MSDs found no statistical differences between HILT and LLLT for pain, disability, or quality of life, concluding that neither demonstrated clear superiority.
Oral Mucositis
Class IV laser therapy showed particular promise for chemotherapy-induced oral mucositis. A clinical and experimental study demonstrated that high-power laser therapy was more effective than low-power laser in improving OM lesion healing, reducing inflammatory burden, preserving tissue integrity, and promoting new arteriole formation within granulation tissue.
Wound Healing
A service evaluation of Class IV laser (K-Laser, four wavelengths: 660/800/905/970 nm) for hard-to-heal leg ulcers found that wounds which had been increasing in size by 0.56%/day reversed to decreasing by 1.12%/day after initiating twice-weekly laser therapy, with 89.5% of patients achieving satisfactory reduction. Cost analysis suggested positive savings, though the sample was small (n = 19). A narrative review of HILT in wound healing found all selected studies demonstrated favorable results, but concluded that insufficient data currently support HILT as a standalone wound management tool.
Mechanisms of Action
HILT produces therapeutic effects through photobiomodulation at higher power densities, enabling deeper tissue penetration (up to 10–12 cm vs. 1–3 cm for LLLT). The mechanisms include:
- Photobiomodulation: absorption by cytochrome c oxidase → increased mitochondrial ATP production → enhanced cellular metabolism
- Neural inhibition: decreased conduction velocity of A-delta and C fibers → reduced pain signal transmission
- Anti-inflammatory: reduced NF-κB, TNF-α, IL-6; increased anti-inflammatory mediators
- Endorphin and serotonin release: central pain modulation
- Tissue repair: enhanced fibroblast proliferation, collagen synthesis, VEGF-mediated angiogenesis
- *Safety Profile
Class IV lasers carry inherent risks due to their power classification — they can cause permanent eye damage from direct or diffuse beam reflections and potential skin burns, requiring mandatory protective eyewear and safety protocols. However, when used therapeutically with appropriate protocols, clinical studies consistently report no serious adverse events. An in vitro study confirmed high-power laser modulates mitochondrial function and redox balance without cytotoxicity at appropriate parameters. Skin photosensitivity episodes may occur, particularly in individuals with darker skin tones (higher melanin absorption).